Atea Pharmaceuticals, Inc. financial statements
Atea Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 158.35M | 10-K |
| Cash and equivalents | USD 95.71M | 10-Q |
| Total debt | USD 843K | EODHD |
Atea Pharmaceuticals, Inc. financials on 6ix · Atea Pharmaceuticals, Inc. on 6ix